James Fraser

Title: James Fraser - Innovator in Immunosuppressive Drug Discovery

Introduction

James Fraser is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of immunology through his innovative research and patent work. His expertise lies in identifying compounds that can induce immunosuppression, which is crucial for various medical applications.

Latest Patents

Fraser holds a patent for a method titled "Screening assay for the identification of novel immunosuppressives." This patent describes a technique for identifying compounds capable of inducing immunosuppression by inhibiting the CD28 signal transduction pathway in T cells. The method involves exposing cultured T cells to one or more test compounds, which are derived from a T cell line that incorporates a specific DNA sequence. The T cells are cultured under conditions that activate both the T cell receptor and the CD28 receptor, leading to enhanced expression of a marker gene. Compounds that inhibit the expression of this marker gene are considered potential candidates for immunosuppressive drugs. Fraser's work in this area is groundbreaking and has the potential to impact therapeutic strategies significantly.

Career Highlights

James Fraser is affiliated with the University of California, where he conducts his research. His work has led to advancements in understanding the mechanisms of immunosuppression and the development of new therapeutic agents. With 1 patent to his name, Fraser continues to push the boundaries of immunological research.

Collaborations

Fraser collaborates with Arthur Weiss, a fellow researcher in the field. Their partnership enhances the depth and breadth of their research, contributing to the advancement of immunology.

Conclusion

James Fraser is a prominent figure in the field of immunology, with a focus on developing novel immunosuppressive drugs. His innovative patent work and collaboration with other experts highlight his commitment to advancing medical science.